(Total Views: 623)
Posted On: 08/06/2020 5:46:43 PM
Post# of 151796
Couldn't agree more on the questions. The next Q&A we should all make a concerted effort to get a handful of valuable questions asked. I would have loved to tackle the interim, e.g. 180 vs 195, asked last time. Would also like to hear Nader talk about ways we could potentially speed up enrollment.
That's what is ultimately killing the stock price... the speed of enrollment. It's the reason we're in a constant state of waiting, waiting, waiting bc it's damn hard to recruit patients when the FDA is touting an inferior drug as the standard of care. Patients hear that phrase and assume it's the best possible treatment they can get, so why opt for an experimental shot?
That's what is ultimately killing the stock price... the speed of enrollment. It's the reason we're in a constant state of waiting, waiting, waiting bc it's damn hard to recruit patients when the FDA is touting an inferior drug as the standard of care. Patients hear that phrase and assume it's the best possible treatment they can get, so why opt for an experimental shot?
(4)
(0)Scroll down for more posts ▼
